Hiroshi Ikenuma
Obu, 4748511, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
11C-labeling of 20(S)-protopanaxadiol, an aglycon of ginsenoside, based on the use of Pd(0)-mediated rapid C-[11C]methylation of boronic precursors.
Journal: Bioorganic & medicinal chemistry letters
Published: June 10, 2025
Plasma IL-6 Levels as a Biomarker for Behavioral Changes in Alzheimer's Disease.
Journal: Neuroimmunomodulation
Published: May 07, 2025
Leptin and inflammatory pathways in the Alzheimer's disease continuum: Implications for glial activation and neuropsychiatric symptoms.
Journal: Brain, behavior, & immunity - health
Published: December 13, 2024
First-in-Human Study of [11C]NCGG401 for Imaging Colony-Stimulating Factor 1 Receptors in the Brain.
First-in-Human Study of [11C]NCGG401 for Imaging Colony-Stimulating Factor 1 Receptors in the Brain.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 28, 2024
Evaluation of specific binding of [11C]TZ7774 to the receptor-interacting protein kinase 1 (RIPK1) in the brain.
Journal: American journal of nuclear medicine and molecular imaging
Published: May 23, 2024
Trait-anxiety and glial-related neuroinflammation of the amygdala and its associated regions in Alzheimer's disease: A significant correlation.
Journal: Brain, behavior, & immunity - health
Published: February 24, 2024
A novel PET probe to selectively image heat shock protein 90α/β isoforms in the brain.
Journal: EJNMMI radiopharmacy and chemistry
Published: November 13, 2023
Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
Journal: EJNMMI radiopharmacy and chemistry
Published: August 30, 2023
Neuroimaging biomarkers of glial activation for predicting the annual cognitive function decline in patients with Alzheimer's disease.
Journal: Brain, behavior, and immunity
Published: April 13, 2023
Development of a novel PET ligand, [11C]GO289 targeting CK2 expressed in the brain.
Journal: Bioorganic & medicinal chemistry letters
Published: March 16, 2023
11C-Labeling of acyclic retinoid peretinoin by rapid C-[11C]methylation to disclose novel brain permeability and central nervous system activities hidden in antitumor agent.
Journal: Bioorganic & medicinal chemistry letters
Published: December 02, 2022
Last Updated: 09/26/2026